Nifty

:

25069.20

Sensex

:

81785.74

-44.80 (-0.18%)
-118.96 (-0.15%)

Login

Nifty
Sensex

:
:

25069.20
81785.74

-44.80 (-0.18%)
-118.96 (-0.15%)

Sun Pharma Advanced Research Company Ltd.

Pharmaceuticals & Drugs - Global

Rating :

34/99

BSE: 532872 | NSE: SPARC

Watchlist

NSE BSE

143.67

15-Sep-2025

Open
High
Low
Previous Close

143.1
145.35
143.1
143.10

Volume
Traded Value (lacs)
52 Week High
52 Week Low

165952
23906018.22
241
109.3

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

4,669.87
N/A
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

4,926.09
N/A
-17.30

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-7.78
-22.27
-33.01

EBITDA CAGR (%)

10 Years
5 Years
3 Years

17.87
19.38
8.58

PAT CAGR (%)

10 Years
5 Years
3 Years

17.30
17.96
15.45

P:E (Median)

8 Years
5 Years
3 Years

-
-
-

P:BV (Average)

8 Years
5 Years
3 Years

18.57
18.57
18.57

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-13.88
-13.88
-13.88

Earnings Forecasts:

(Updated: 15-09-2025)

Description 2024 2025 2026 2027
Adj EPS -10.55
P/E Ratio -13.62
Revenue 71.77
EBITDA -323.14
Net Income -342.51
ROA -80.54
P/B Ratio -21.48
ROE
FCFF -364.5
FCFF Yield -7.38
Net Debt 266.96
BVPS -6.69

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var%
Net Sales 9.64 16.81 -42.65% 27.19 16.56 64.19% 14.91 13.86 7.58% 12.86 21.18 -39.28%
Expenses 61.97 111.93 -44.64% 81.11 124.08 -34.63% 89.29 116.48 -23.34% 116.71 112.65 3.60%
EBITDA -52.33 -95.12 - -53.92 -107.52 - -74.38 -102.62 - -103.85 -91.47 -
EBIDTM -542.84% -565.85% -198.31% -649.28% -498.86% -740.40% -807.54% -431.87%
Other Income 9.02 1.56 478.21% 0.00 4.40 -100.00% 0.19 6.39 -97.03% 0.04 8.49 -99.53%
Interest 6.18 0.52 1,088.46% 4.51 0.88 412.50% 2.77 0.26 965.38% 1.11 0.26 326.92%
Depreciation 2.54 2.76 -7.97% 2.55 2.69 -5.20% 2.75 3.16 -12.97% 2.77 3.18 -12.89%
PBT -52.03 -96.84 - -60.98 -106.69 - -79.71 -99.65 - -107.69 -86.42 -
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT -52.03 -96.84 - -60.98 -106.69 - -79.71 -99.65 - -107.69 -86.42 -
PATM -539.73% -576.09% -224.27% -644.26% -534.61% -718.98% -837.40% -408.03%
EPS -1.60 -2.98 - -1.88 -3.29 - -2.46 -3.07 - -3.32 -2.66 -

Description Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var%
Net Sales 9.64 16.81 -42.65% 27.19 16.56 64.19% 14.91 13.86 7.58% 12.86 21.18 -39.28%
Expenses 61.72 110.17 -43.98% 80.37 122.39 -34.33% 88.60 116.48 -23.94% 115.77 112.65 2.77%
EBITDA -52.08 -93.36 - -53.18 -105.83 - -73.69 -102.62 - -102.91 -91.47 -
EBIDTM -540.25% -555.38% -195.59% -639.07% -494.23% -740.40% -800.23% -431.87%
Other Income 9.14 1.56 485.90% 0.00 4.40 -100.00% 0.19 6.39 -97.03% 0.04 8.49 -99.53%
Interest 6.19 0.56 1,005.36% 4.54 0.91 398.90% 2.80 0.26 976.92% 1.14 0.26 338.46%
Depreciation 2.68 3.14 -14.65% 2.95 3.07 -3.91% 3.14 3.16 -0.63% 3.16 3.18 -0.63%
PBT -51.81 -95.50 - -60.67 -105.41 - -79.44 -99.65 - -107.17 -86.42 -
Tax 0.06 0.40 -85.00% -0.90 0.38 - 0.07 0.00 0 0.16 0.00 0
PAT -51.87 -95.90 - -59.77 -105.79 - -79.51 -99.65 - -107.33 -86.42 -
PATM -538.07% -570.49% -219.82% -638.83% -533.27% -718.98% -834.60% -408.03%
EPS -1.60 -2.96 - -1.84 -3.26 - -2.45 -3.07 - -3.31 -2.66 -

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 64.60 71.77 75.55 238.78 137.25 252.96 76.81 182.87 78.26 181.02 161.28 Net Sales Growth -5.57% -5.00% -68.36% 73.97% -45.74% 229.33% -58.00% 133.67% -56.77% 12.24% Cost Of Goods Sold 23.72 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Gross Profit 40.88 71.77 75.55 238.78 137.25 252.96 76.81 182.87 78.26 181.02 161.28 GP Margin 63.28% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% Total Expenditure 349.08 399.04 479.34 452.84 324.00 387.93 386.83 334.16 320.87 303.72 224.48 Power & Fuel Cost - 6.33 6.14 5.75 4.62 4.60 5.14 5.08 4.92 4.67 4.49 % Of Sales - 8.82% 8.13% 2.41% 3.37% 1.82% 6.69% 2.78% 6.29% 2.58% 2.78% Employee Cost - 108.96 118.53 107.00 98.31 91.59 93.09 81.06 100.92 84.30 56.60 % Of Sales - 151.82% 156.89% 44.81% 71.63% 36.21% 121.20% 44.33% 128.95% 46.57% 35.09% Manufacturing Exp. - 114.52 140.23 180.31 134.27 209.78 30.47 17.81 31.79 29.39 26.42 % Of Sales - 159.57% 185.61% 75.51% 97.83% 82.93% 39.67% 9.74% 40.62% 16.24% 16.38% General & Admin Exp. - 164.48 207.41 154.91 84.39 78.49 251.32 221.40 181.18 180.29 131.88 % Of Sales - 229.18% 274.53% 64.88% 61.49% 31.03% 327.20% 121.07% 231.51% 99.60% 81.77% Selling & Distn. Exp. - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 % Of Sales - 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% Miscellaneous Exp. - 4.75 7.03 4.87 2.41 3.48 6.81 8.80 2.05 5.06 0.00 % Of Sales - 6.62% 9.31% 2.04% 1.76% 1.38% 8.87% 4.81% 2.62% 2.80% 3.15% EBITDA -284.48 -327.27 -403.79 -214.06 -186.75 -134.97 -310.02 -151.29 -242.61 -122.70 -63.20 EBITDA Margin -440.37% -456.00% -534.47% -89.65% -136.07% -53.36% -403.62% -82.73% -310.01% -67.78% -39.19% Other Income 9.25 1.79 29.47 10.88 6.84 5.41 9.76 13.51 4.94 13.72 2.94 Interest 14.57 8.91 1.66 7.63 13.33 10.65 2.67 0.09 0.12 1.82 2.16 Depreciation 10.61 10.83 12.13 11.77 10.16 10.92 9.48 7.55 8.18 8.24 7.58 PBT -300.41 -345.22 -388.11 -222.58 -203.40 -151.14 -312.40 -145.43 -245.97 -119.04 -69.99 Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Rate 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% PAT -300.41 -345.22 -388.11 -222.58 -203.40 -151.14 -312.40 -145.43 -197.00 -119.04 -69.99 PAT before Minority Interest -300.41 -345.22 -388.11 -222.58 -203.40 -151.14 -312.40 -145.43 -197.00 -119.04 -69.99 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin -465.03% -481.01% -513.71% -93.22% -148.20% -59.75% -406.72% -79.53% -251.73% -65.76% -43.40% PAT Growth 0.00% - - - - - - - - - EPS -9.26 -10.64 -11.96 -6.86 -6.27 -4.66 -9.63 -4.48 -6.07 -3.67 -2.16

Description TTM Mar 25 Mar 24 Mar 23
Net Sales 64.60 71.77 75.55 238.78 Net Sales Growth -5.57% -5.00% -68.36% Cost Of Goods Sold 23.72 0.00 0.00 0.00 Gross Profit 40.88 71.77 75.55 238.78 GP Margin 63.28% 100% 100% 100% Total Expenditure 346.46 394.90 477.64 452.84 Power & Fuel Cost - 6.33 6.14 5.75 % Of Sales - 8.82% 8.13% 2.41% Employee Cost - 153.58 141.84 107.00 % Of Sales - 213.99% 187.74% 44.81% Manufacturing Exp. - 114.52 140.23 180.31 % Of Sales - 159.57% 185.61% 75.51% General & Admin Exp. - 115.92 182.20 154.91 % Of Sales - 161.52% 241.16% 64.88% Selling & Distn. Exp. - 0.00 0.00 0.00 % Of Sales - 0% 0% 0% Miscellaneous Exp. - 4.55 7.23 4.87 % Of Sales - 6.34% 9.57% 2.04% EBITDA -281.86 -323.13 -402.09 -214.06 EBITDA Margin -436.32% -450.23% -532.22% -89.65% Other Income 9.37 1.79 29.47 10.88 Interest 14.67 9.04 1.69 7.63 Depreciation 11.93 12.39 12.51 11.77 PBT -299.09 -342.78 -386.83 -222.58 Tax -0.61 -0.27 0.38 0.00 Tax Rate 0.20% 0.08% -0.10% 0.00% PAT -298.48 -342.51 -387.21 -222.58 PAT before Minority Interest -298.48 -342.51 -387.21 -222.58 Minority Interest 0.00 0.00 0.00 0.00 PAT Margin -462.04% -477.23% -512.52% -93.22% PAT Growth 0.00% - - EPS -9.20 -10.56 -11.93 -6.86

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds -220.62 124.86 512.78 31.23 -168.25 -18.64 296.24 184.72 158.16 31.80 Share Capital 32.45 32.45 32.45 27.19 26.21 26.21 26.21 25.09 24.69 23.67 Total Reserves -253.07 92.40 480.32 -230.22 -194.46 -44.84 270.03 67.96 133.47 6.23 Non-Current Liabilities 176.17 117.59 138.41 77.43 164.59 55.85 7.20 11.98 10.36 10.02 Secured Loans 0.00 0.00 0.00 0.00 112.50 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 100.00 0.00 0.00 0.00 0.00 6.38 1.09 1.64 2.18 2.73 Long Term Provisions 7.68 6.05 8.14 8.15 8.63 10.23 6.11 10.34 8.18 7.30 Current Liabilities 373.72 243.89 178.95 171.43 233.35 235.36 95.04 116.11 108.03 124.84 Trade Payables 124.40 149.82 148.25 72.19 91.17 158.84 82.92 102.48 94.45 58.15 Other Current Liabilities 85.40 43.52 24.15 93.96 56.44 11.20 7.66 9.42 9.81 12.09 Short Term Borrowings 158.19 47.00 0.05 0.00 80.00 60.00 0.00 0.10 0.41 52.48 Short Term Provisions 5.74 3.55 6.49 5.28 5.75 5.31 4.46 4.10 3.35 2.12 Total Liabilities 329.27 486.34 830.14 280.09 229.69 272.57 398.48 312.81 276.55 166.66 Net Block 95.33 102.65 105.75 91.87 90.56 103.86 57.56 51.74 69.16 69.96 Gross Block 152.70 151.87 146.22 133.15 122.51 135.50 80.22 67.17 77.28 106.82 Accumulated Depreciation 57.37 49.22 40.47 41.28 31.95 31.64 22.66 15.44 8.12 36.86 Non Current Assets 304.02 239.93 375.16 208.93 166.58 205.38 141.09 137.59 118.27 98.88 Capital Work in Progress 54.15 43.79 27.00 26.37 5.23 32.07 24.13 3.27 1.47 0.87 Non Current Investment 0.42 0.42 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 128.19 67.67 64.80 67.83 70.64 69.24 59.29 82.48 47.45 27.99 Other Non Current Assets 25.93 25.40 177.61 22.87 0.15 0.20 0.12 0.10 0.19 0.07 Current Assets 25.26 246.41 454.96 71.15 63.11 67.19 257.38 175.22 158.28 66.59 Current Investments 0.00 1.80 290.90 11.66 6.43 8.49 210.58 107.57 9.65 0.00 Inventories 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Sundry Debtors 16.06 15.53 32.71 27.74 17.58 16.05 10.17 17.56 38.90 9.16 Cash & Bank 1.19 155.06 111.58 1.23 9.31 0.46 0.68 1.32 70.31 12.75 Other Current Assets 8.02 19.58 3.98 2.50 29.80 42.19 35.96 48.77 39.43 44.69 Short Term Loans & Adv. 3.88 54.43 15.80 28.02 21.70 39.33 33.39 46.73 37.48 43.35 Net Current Assets -348.46 2.52 276.02 -100.28 -170.24 -168.17 162.34 59.11 50.25 -58.24 Total Assets 329.28 486.34 830.12 280.08 229.69 272.57 398.47 312.81 276.55 166.65

Description Mar 25 Mar 24 Mar 23
Shareholder's Funds -216.95 125.76 512.78 Share Capital 32.45 32.45 32.45 Total Reserves -249.40 93.30 480.32 Non-Current Liabilities 175.93 122.97 138.41 Secured Loans 0.00 0.00 0.00 Unsecured Loans 100.00 0.00 0.00 Long Term Provisions 7.68 6.05 8.14 Current Liabilities 374.24 265.06 178.95 Trade Payables 113.92 142.29 148.25 Other Current Liabilities 94.24 61.88 24.15 Short Term Borrowings 158.19 47.00 0.05 Short Term Provisions 7.89 13.89 6.49 Total Liabilities 333.22 513.79 830.14 Net Block 98.76 107.53 105.75 Gross Block 158.11 157.14 146.22 Accumulated Depreciation 59.35 49.60 40.47 Non Current Assets 307.03 244.39 375.16 Capital Work in Progress 54.15 43.79 27.00 Non Current Investment 0.00 0.00 0.00 Long Term Loans & Adv. 128.19 67.67 64.80 Other Non Current Assets 25.93 25.40 177.61 Current Assets 26.20 269.39 454.96 Current Investments 0.00 1.80 290.90 Inventories 0.00 0.00 0.00 Sundry Debtors 16.06 15.53 32.71 Cash & Bank 1.96 155.33 111.58 Other Current Assets 8.18 42.24 3.98 Short Term Loans & Adv. 3.98 54.48 15.80 Net Current Assets -348.04 4.33 276.02 Total Assets 333.23 513.78 830.12

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity -362.41 -429.43 -69.12 -208.23 -151.90 -210.81 -171.91 -182.77 -128.04 -44.21 PBT -345.22 -388.11 -222.58 -203.40 -151.14 -312.40 -145.43 -245.97 -119.04 -69.99 Adjustment 18.83 -11.33 6.99 16.67 48.75 9.44 -21.77 3.82 -1.14 9.25 Changes in Working Capital -46.80 -25.88 141.11 -26.05 -47.88 102.02 -0.17 20.48 12.86 30.41 Cash after chg. in Working capital -373.20 -425.32 -74.48 -212.78 -150.26 -200.95 -167.38 -221.68 -107.32 -30.34 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid 10.79 -4.11 5.37 4.54 -1.63 -9.86 -4.54 -10.08 -20.72 -13.87 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 48.98 0.00 0.00 Cash From Investing Activity 157.66 391.11 -548.28 -29.17 1.56 155.35 -102.19 -104.62 -6.61 -13.08 Net Fixed Assets -11.19 -22.44 -13.70 -31.78 39.83 -63.22 -33.91 8.31 28.94 -11.29 Net Investments 1.80 288.68 -279.24 -5.23 2.06 202.09 -103.01 -97.92 -9.65 0.00 Others 167.05 124.87 -255.34 7.84 -40.33 16.48 34.73 -15.01 -25.90 -1.79 Cash from Financing Activity 200.88 42.80 616.76 229.32 159.28 55.46 274.25 224.01 194.25 50.55 Net Cash Inflow / Outflow -3.87 4.48 -0.64 -8.08 8.95 0.00 0.15 -63.38 59.60 -6.74 Opening Cash & Equivalents 5.06 0.58 1.22 9.30 0.35 0.35 0.20 63.58 4.00 10.63 Closing Cash & Equivalent 1.19 5.06 0.58 1.22 9.30 0.35 0.35 0.20 63.58 4.00

Description Mar 25 Mar 24 Mar 23
Cash From Operating Activity -360.29 -429.19 -69.12 PBT -342.78 -386.83 -222.58 Adjustment 20.52 -10.91 6.99 Changes in Working Capital -46.86 -27.33 141.11 Cash after chg. in Working capital -369.12 -425.08 -74.48 Interest Paid 0.00 0.00 0.00 Tax Paid 8.83 -4.11 5.37 Other Direct Exp. Paid 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 Cash From Investing Activity 157.66 391.53 -548.28 Net Fixed Assets -11.19 -22.44 Net Investments 1.80 288.68 Others 167.05 125.29 Cash from Financing Activity 199.26 42.41 616.76 Net Cash Inflow / Outflow -3.38 4.74 -0.64 Opening Cash & Equivalents 5.33 0.58 1.22 Closing Cash & Equivalent 1.96 5.33 0.58

Financial Ratios

Standalone /

Consolidated

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) -6.80 3.85 15.80 -7.47 -6.42 -0.71 11.30 3.71 6.41 1.21 ROA -84.65% -58.96% -40.10% -79.80% -60.18% -93.11% -40.89% -66.85% -53.72% -44.68% ROE 0.00% -121.73% -143.72% 0.00% 0.00% -225.08% -74.72% -156.84% -127.40% -109.16% ROCE -321.18% -112.88% -69.44% -225.57% -254.10% -178.95% -59.95% -113.05% -94.66% -71.37% Fixed Asset Turnover 0.47 0.51 1.71 1.07 1.96 0.71 2.48 1.08 1.97 1.59 Receivable days 80.33 116.55 46.20 60.25 24.26 62.28 27.67 131.66 48.45 32.87 Inventory Days 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Payable days 0.00 0.00 0.00 0.00 0.00 316.55 300.15 244.72 218.01 163.03 Cash Conversion Cycle 80.33 116.55 46.20 60.25 24.26 -254.27 -272.48 -113.05 -169.56 -130.16 Total Debt/Equity -1.17 0.38 0.00 -0.37 -1.37 -3.59 0.01 0.02 0.02 1.94 Interest Cover -37.76 -233.48 -28.15 -14.26 -13.19 -115.79 -1547.78 -1596.71 -64.41 -31.45

Description Mar 25 Mar 24 Mar 23
Book Value (Rs.) -6.68 3.88 15.80 ROA -80.88% -57.63% -26.81% ROE 0.00% -121.28% -43.41% ROCE -311.92% -112.35% -41.91% Fixed Asset Turnover 0.46 0.50 1.63 Receivable days 80.33 116.55 50.01 Inventory Days 0.00 0.00 0.00 Payable days 0.00 0.00 0.00 Cash Conversion Cycle 80.33 116.55 50.01 Total Debt/Equity -1.19 0.37 0.00 Interest Cover -36.92 -227.27 -28.15

Top Investors:

sun pharmaceutical industries key employees benefit trust

lakshdeep investments & finance (p) ltd.

vijay mohanlal parekh

paresh mohanlal parekh

enam holdings pvt ltd

Annual Reports:

News Update:

Sun Pharma Adv. Res - Quarterly Results
4th Aug 2025, 14:10 PM

Read More
Sun Pharma Advanced Research incorporates wholly owned subsidiary
7th Jul 2025, 09:12 AM

The Certificate of Incorporation has been issued by the Ministry of Corporate Affairs, Government of India, on July 5, 2025
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback